A systematic review of immune checkpoint inhibitors in endometrial cancer - Summary - MDSpire

A systematic review of immune checkpoint inhibitors in endometrial cancer

  • By

  • Na Zhu

  • Chaihong Zhang

  • June 8, 2026

  • 0 min

Share

Objective:

Emphasize the significance of immune checkpoint inhibitors in endometrial cancer.

Key Findings:
  • Add the number of journals analyzed for WoSCC.
Interpretation:

Make it more concise and directly linked to findings.

Limitations:
  • Add a limitation regarding potential publication bias.
Conclusion:

Reiterate the importance of findings for guiding future research.

Original Source(s)

A systematic review of immune checkpoint inhibitors in endometrial cancer

  • by Na Zhu, Chaihong Zhang

  • June 8, 2026

Related Content

Rearming mesenchymal stem cells with engineering strategies to combat cancer

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression

Primary diffuse large b-cell lymphoma of the lip: a case report and literature review